Healthcare Sector Stocks
The Healthcare sector has a total of 1045 stocks, with a combined market cap of $9.31 trillion, total revenue of $4.66 trillion and a weighted average PE ratio of 48.76.
Market Cap
9.31T
Revenue
4.66T
Profits
190.89B
PE Ratio
48.76
Profit Margin
4.09%
Dividend Yield
0.38%
1045 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.06T | 0.11% | 1,974,103 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 655.37B | 0.27% | 7,188,863 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 470.55B | 0.73% | 4,429,513 | 64.39B |
| 4 | MRK | Merck & Co., Inc. | 366.84B | -0.06% | 7,700,986 | 66.57B |
| 5 | UNH | UnitedHealth Group Incorporated | 339.14B | 0.33% | 4,677,126 | 450.53B |
| 6 | NVS | Novartis AG | 277.45B | 0.98% | 1,949,456 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 256.85B | -0.26% | 1,726,645 | 61.37B |
| 8 | TMO | Thermo Fisher Scientific Inc. | 250.91B | 0.53% | 1,905,729 | 46.34B |
| 9 | AMGN | Amgen Inc. | 226.05B | 0.85% | 2,917,875 | 38.10B |
| 10 | GILD | Gilead Sciences, Inc. | 188.73B | 0.85% | 5,081,994 | 30.46B |
| 11 | ABT | Abbott Laboratories | 174.73B | -0.31% | 6,802,511 | 46.59B |
| 12 | NVO | Novo Nordisk A/S | 169.69B | -0.23% | 11,428,805 | 50.34B |
| 13 | PFE | Pfizer Inc. | 163.69B | 0.17% | 24,950,465 | 63.70B |
| 14 | DHR | Danaher Corporation | 159.81B | 1.27% | 4,929,773 | 25.11B |
| 15 | ISRG | Intuitive Surgical, Inc. | 146.54B | 2.37% | 2,570,792 | 11.03B |
| 16 | VRTX | Vertex Pharmaceuticals Incorporated | 133.74B | 0.28% | 824,740 | 12.59B |
| 17 | BMY | Bristol-Myers Squibb Company | 130.49B | 1.62% | 14,018,713 | 49.19B |
| 18 | MDT | Medtronic plc | 114.48B | 0.97% | 22,549,329 | 37.54B |
| 19 | CVS | CVS Health Corporation | 112.36B | -1.44% | 7,900,436 | 412.65B |
| 20 | SYK | Stryker Corporation | 105.60B | 1.08% | 2,492,109 | 25.84B |
| 21 | MCK | McKesson Corporation | 99.84B | -1.19% | 550,012 | 410.98B |
| 22 | GSK | GSK plc | 98.80B | 0.93% | 3,586,711 | 44.05B |
| 23 | SNY | Sanofi | 98.08B | 0.17% | 2,173,740 | 55.89B |
| 24 | HCA | HCA Healthcare, Inc. | 93.66B | -0.69% | 1,106,217 | 78.01B |
| 25 | ELV | Elevance Health, Inc. | 85.57B | -0.38% | 1,335,625 | 201.11B |
| 26 | MRNA | Moderna, Inc. | 78.76B | -0.80% | 13,359,641 | 2.23B |
| 27 | REGN | Regeneron Pharmaceuticals, Inc. | 75.12B | -4.54% | 1,149,832 | 15.53B |
| 28 | CI | The Cigna Group | 71.83B | -0.07% | 1,752,755 | 282.38B |
| 29 | BSX | Boston Scientific Corporation | 63.93B | 0.43% | 21,779,647 | 21.00B |
| 30 | ARGX | argenx SE | 60.06B | 1.33% | 264,661 | 5.32B |
| 31 | NTRA | Natera, Inc. | 59.35B | -0.19% | 1,650,434 | 2.71B |
| 32 | TAK | Takeda Pharmaceutical Company Limited | 58.22B | 0.21% | 2,063,036 | 28.42B |
| 33 | COR | Cencora, Inc. | 57.98B | -1.01% | 1,521,364 | 332.77B |
| 34 | CAH | Cardinal Health, Inc. | 51.01B | 0.03% | 2,392,865 | 254.25B |
| 35 | BDX | Becton, Dickinson and Company | 50.07B | 0.01% | 1,885,644 | 22.48B |
| 36 | EW | Edwards Lifesciences Corporation | 50.05B | 0.63% | 3,228,054 | 6.51B |
| 37 | A | Agilent Technologies, Inc. | 49.40B | 1.40% | 2,194,086 | 7.37B |
| 38 | HUM | Humana Inc. | 46.79B | -2.09% | 1,492,913 | 145.68B |
| 39 | MDLN | Medline Inc. | 46.11B | 1.07% | 10,072,237 | 29.94B |
| 40 | VEEV | Veeva Systems Inc. | 45.33B | -0.26% | 1,377,020 | 3.46B |
| 41 | TEVA | Teva Pharmaceutical Industries Limited | 45.31B | -0.79% | 4,306,548 | 17.32B |
| 42 | IQV | IQVIA Holdings Inc. | 44.60B | 0.22% | 1,620,939 | 16.98B |
| 43 | WAT | Waters Corporation | 43.52B | 2.17% | 981,495 | 4.64B |
| 44 | RVMD | Revolution Medicines, Inc. | 43.24B | -1.58% | 1,814,810 | - |
| 45 | ONC | BeOne Medicines AG | 41.73B | 1.70% | 350,550 | 6.13B |
| 46 | IDXX | IDEXX Laboratories, Inc. | 41.68B | 1.89% | 391,987 | 4.55B |
| 47 | ILMN | Illumina, Inc. | 41.06B | 0.70% | 2,980,165 | 4.49B |
| 48 | HLN | Haleon plc | 39.73B | -0.97% | 15,714,475 | 14.80B |
| 49 | ALNY | Alnylam Pharmaceuticals, Inc. | 34.17B | -0.23% | 1,147,873 | 4.80B |
| 50 | BIIB | Biogen Inc. | 33.79B | 0.48% | 1,332,340 | 10.03B |
| 51 | RPRX | Royalty Pharma plc | 33.56B | 0.27% | 1,862,792 | 2.54B |
| 52 | DXCM | DexCom, Inc. | 32.71B | 0.07% | 3,411,255 | 4.97B |
| 53 | RMD | ResMed Inc. | 31.77B | 0.05% | 862,828 | 5.65B |
| 54 | ALC | Alcon Inc. | 31.17B | 1.23% | 2,320,444 | 10.86B |
| 55 | MTD | Mettler-Toledo International Inc. | 30.96B | 2.22% | 186,454 | 4.13B |
| 56 | CNC | Centene Corporation | 30.89B | 1.15% | 5,165,077 | 180.30B |
| 57 | GEHC | GE HealthCare Technologies Inc. | 30.16B | 0.23% | 4,166,165 | 21.27B |
| 58 | ZTS | Zoetis Inc. | 29.52B | 0.53% | 3,907,362 | 9.53B |
| 59 | ROIV | Roivant Sciences Ltd. | 26.71B | 3.30% | 6,972,001 | 7.53M |
| 60 | WST | West Pharmaceutical Services, Inc. | 26.44B | 1.41% | 567,556 | 3.33B |
| 61 | DGX | Quest Diagnostics Incorporated | 26.23B | 0.55% | 1,036,022 | 11.56B |
| 62 | INSM | Insmed Incorporated | 25.70B | -0.14% | 1,744,370 | 1.14B |
| 63 | INCY | Incyte Corporation | 25.30B | 0.75% | 1,436,282 | 5.82B |
| 64 | LH | Labcorp Holdings Inc. | 25.11B | -0.02% | 782,477 | 14.35B |
| 65 | BNTX | BioNTech SE | 24.89B | 0.57% | 785,847 | 3.03B |
| 66 | PHG | Koninklijke Philips N.V. | 24.42B | 0.60% | 835,635 | 20.18B |
| 67 | GH | Guardant Health, Inc. | 23.80B | 0.05% | 1,318,541 | 1.18B |
| 68 | VTRS | Viatris Inc. | 20.98B | 2.47% | 12,377,188 | 14.74B |
| 69 | GMAB | Genmab A/S | 20.92B | 0.11% | 2,794,571 | 4.13B |
| 70 | UTHR | United Therapeutics Corporation | 20.83B | 2.12% | 628,267 | 3.15B |
| 71 | THC | Tenet Healthcare Corporation | 20.77B | -0.69% | 544,751 | 21.81B |
| 72 | STE | STERIS plc | 20.57B | 0.99% | 493,651 | 6.04B |
| 73 | ZBH | Zimmer Biomet Holdings, Inc. | 17.48B | 0.64% | 1,628,334 | 8.51B |
| 74 | MEDP | Medpace Holdings, Inc. | 17.19B | -0.48% | 242,301 | 2.78B |
| 75 | RVTY | Revvity, Inc. | 16.85B | -0.06% | 1,500,527 | 2.91B |
| 76 | JAZZ | Jazz Pharmaceuticals plc | 15.47B | 0.14% | 788,285 | 4.60B |
| 77 | TEM | Tempus AI, Inc. | 15.35B | 0.08% | 6,288,768 | 1.43B |
| 78 | SOLV | Solventum Corporation | 15.24B | 0.04% | 649,157 | 8.31B |
| 79 | ASND | Ascendis Pharma A/S | 15.11B | 1.97% | 747,554 | 1.20B |
| 80 | EXEL | Exelixis, Inc. | 14.46B | 0.36% | 1,278,704 | 2.44B |
| 81 | NBIX | Neurocrine Biosciences, Inc. | 14.28B | 1.47% | 1,431,627 | 3.37B |
| 82 | CRL | Charles River Laboratories International, Inc. | 14.06B | 0.60% | 901,742 | 4.00B |
| 83 | ICLR | ICON Public Limited Company | 13.55B | 1.88% | 1,342,157 | 8.29B |
| 84 | BBIO | BridgeBio Pharma, Inc. | 13.02B | 1.59% | 2,969,260 | 713.07M |
| 85 | HALO | Halozyme Therapeutics, Inc. | 12.81B | -0.89% | 2,236,750 | 1.66B |
| 86 | PEN | Penumbra, Inc. | 12.57B | 0.09% | 189,478 | 1.50B |
| 87 | CORT | Corcept Therapeutics Incorporated | 12.50B | -0.40% | 1,155,321 | 830.81M |
| 88 | SMMT | Summit Therapeutics Inc. | 12.35B | -0.83% | 6,151,131 | - |
| 89 | EHC | Encompass Health Corporation | 12.23B | 0.45% | 991,146 | 6.21B |
| 90 | FMS | Fresenius Medical Care AG | 12.20B | 1.15% | 498,696 | 22.19B |
| 91 | BAX | Baxter International Inc. | 12.14B | 0.51% | 6,171,495 | 11.47B |
| 92 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.95B | 0.09% | 333,656 | 1.28B |
| 93 | BTSG | BrightSpring Health Services, Inc. | 11.78B | -0.09% | 2,030,981 | 14.37B |
| 94 | TXG | 10x Genomics, Inc. | 11.53B | 3.26% | 3,370,730 | 616.91M |
| 95 | BMRN | BioMarin Pharmaceutical Inc. | 11.51B | -1.33% | 2,357,964 | 3.41B |
| 96 | TECH | Bio-Techne Corporation | 11.37B | -0.14% | 3,820,153 | 1.22B |
| 97 | DVA | DaVita Inc. | 11.36B | -0.22% | 439,520 | 14.01B |
| 98 | SNN | Smith & Nephew plc | 11.29B | 0.63% | 826,475 | 6.30B |
| 99 | TWST | Twist Bioscience Corporation | 11.26B | -1.77% | 2,197,180 | 431.80M |
| 100 | ELAN | Elanco Animal Health Incorporated | 11.22B | 0.63% | 6,593,501 | 5.02B |
| 101 | RGEN | Repligen Corporation | 10.95B | 2.32% | 1,567,199 | 785.10M |
| 102 | COO | The Cooper Companies, Inc. | 10.76B | 2.15% | 4,728,874 | 4.24B |
| 103 | RDY | Dr. Reddy's Laboratories Limited | 10.61B | 2.12% | 4,029,552 | 3.50B |
| 104 | UHS | Universal Health Services, Inc. | 10.46B | -0.77% | 765,174 | 18.11B |
| 105 | AVTR | Avantor, Inc. | 10.34B | 0.26% | 9,436,674 | 6.56B |
| 106 | ALGN | Align Technology, Inc. | 10.30B | -1.21% | 886,504 | 4.14B |
| 107 | ENSG | The Ensign Group, Inc. | 10.19B | 0.67% | 322,768 | 5.49B |
| 108 | AXSM | Axsome Therapeutics, Inc. | 10.16B | -0.62% | 707,409 | 776.57M |
| 109 | BIO | Bio-Rad Laboratories, Inc. | 10.10B | -0.87% | 272,637 | 2.59B |
| 110 | GMED | Globus Medical, Inc. | 10.04B | 0.35% | 1,732,290 | 3.14B |
| 111 | KRYS | Krystal Biotech, Inc. | 9.98B | -2.53% | 298,931 | 440.48M |
| 112 | MOH | Molina Healthcare, Inc. | 9.88B | -0.64% | 555,888 | 42.47B |
| 113 | BRKR | Bruker Corporation | 9.64B | -1.40% | 2,612,651 | 3.50B |
| 114 | HSIC | Henry Schein, Inc. | 9.58B | -0.44% | 984,292 | 13.60B |
| 115 | GKOS | Glaukos Corporation | 9.35B | 2.67% | 1,400,531 | 612.84M |
| 116 | KYMR | Kymera Therapeutics, Inc. | 9.31B | 0.04% | 723,653 | 105.00M |
| 117 | QGEN | Qiagen N.V. | 9.31B | 1.88% | 2,746,169 | 2.10B |
| 118 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.25B | -0.70% | 1,589,695 | 669.50M |
| 119 | PODD | Insulet Corporation | 9.23B | -2.22% | 1,724,759 | 3.05B |
| 120 | PTGX | Protagonist Therapeutics, Inc. | 9.22B | 0.41% | 925,462 | 281.99M |
| 121 | CYTK | Cytokinetics, Incorporated | 9.20B | 2.32% | 2,551,194 | 67.67M |
| 122 | OSCR | Oscar Health, Inc. | 9.14B | 0.17% | 4,007,906 | 15.32B |
| 123 | IBRX | ImmunityBio, Inc. | 9.03B | 0.95% | 10,413,580 | 165.79M |
| 124 | CAI | Caris Life Sciences, Inc. | 8.97B | -0.72% | 3,938,623 | 989.61M |
| 125 | PCVX | Vaxcyte, Inc. | 8.67B | 3.66% | 1,848,955 | - |
| 126 | ABVX | ABIVAX Société Anonyme | 8.31B | 6.36% | 1,680,953 | 5.33M |
| 127 | PRAX | Praxis Precision Medicines, Inc. | 7.98B | 1.73% | 436,732 | 7.46M |
| 128 | TGTX | TG Therapeutics, Inc. | 7.97B | -2.16% | 1,442,422 | 799.54M |
| 129 | ATR | AptarGroup, Inc. | 7.91B | 0.47% | 713,332 | 3.93B |
| 130 | IONS | Ionis Pharmaceuticals, Inc. | 7.57B | 2.40% | 3,742,302 | 874.09M |
| 131 | SYRE | Spyre Therapeutics, Inc. | 7.56B | 0.12% | 1,045,536 | - |
| 132 | HNGE | Hinge Health, Inc. | 7.46B | -3.26% | 1,276,561 | 720.06M |
| 133 | HQY | HealthEquity, Inc. | 7.32B | 0.22% | 1,495,807 | 1.36B |
| 134 | AMRX | Amneal Pharmaceuticals, Inc. | 7.14B | 3.69% | 2,989,109 | 3.12B |
| 135 | IMVT | Immunovant, Inc. | 6.92B | 0.57% | 1,229,311 | - |
| 136 | PACS | PACS Group, Inc. | 6.82B | 4.26% | 1,101,319 | 5.55B |
| 137 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.79B | -0.10% | 897,361 | 239.92M |
| 138 | ALKS | Alkermes plc | 6.74B | -1.71% | 2,356,249 | 1.67B |
| 139 | HIMS | Hims & Hers Health, Inc. | 6.71B | -2.18% | 6,524,604 | 2.58B |
| 140 | CHE | Chemed Corporation | 6.69B | 0.42% | 215,999 | 2.60B |
| 141 | BLTE | Belite Bio, Inc | 6.68B | -0.84% | 127,333 | - |
| 142 | GRFS | Grifols, S.A. | 6.61B | 0.82% | 597,124 | 8.48B |
| 143 | LQDA | Liquidia Corporation | 6.59B | 7.66% | 1,206,349 | 450.91M |
| 144 | LNTH | Lantheus Holdings, Inc. | 6.51B | - | 1,248,097 | 1.56B |
| 145 | LGND | Ligand Pharmaceuticals Incorporated | 6.26B | 4.17% | 241,742 | 290.54M |
| 146 | CGON | CG Oncology, Inc. | 6.17B | 3.66% | 1,759,584 | 6.23M |
| 147 | BLCO | Bausch + Lomb Corporation | 6.05B | 0.53% | 418,814 | 5.32B |
| 148 | SRRK | Scholar Rock Holding Corporation | 5.98B | 1.03% | 1,569,485 | - |
| 149 | KNSA | Kiniksa Pharmaceuticals International, plc | 5.94B | 1.36% | 734,142 | 840.85M |
| 150 | GRAL | GRAIL, Inc. | 5.92B | 4.52% | 1,110,432 | 165.26M |
| 151 | STVN | Stevanato Group S.p.A. | 5.85B | 1.33% | 306,631 | 1.40B |
| 152 | TVTX | Travere Therapeutics, Inc. | 5.80B | 3.58% | 1,235,028 | 591.33M |
| 153 | MMED | MiniMed Group, Inc. | 5.76B | 2.55% | 3,730,150 | 3.22B |
| 154 | BLLN | BillionToOne, Inc. | 5.74B | -1.10% | 343,643 | 397.41M |
| 155 | MIRM | Mirum Pharmaceuticals, Inc. | 5.71B | -1.94% | 1,236,868 | 618.07M |
| 156 | RDNT | RadNet, Inc. | 5.65B | 1.44% | 528,179 | 2.27B |
| 157 | KOD | Kodiak Sciences Inc. | 5.64B | 177.96% | 38,551,966 | - |
| 158 | ORKA | Oruka Therapeutics, Inc. | 5.57B | -0.32% | 923,350 | - |
| 159 | COGT | Cogent Biosciences, Inc. | 5.53B | -1.39% | 2,212,923 | - |
| 160 | PTCT | PTC Therapeutics, Inc. | 5.50B | 5.23% | 1,913,789 | 1.01B |
| 161 | TFX | Teleflex Incorporated | 5.40B | 4.35% | 1,578,208 | 2.25B |
| 162 | SHC | Sotera Health Company | 5.27B | 0.60% | 1,391,401 | 1.22B |
| 163 | CRSP | CRISPR Therapeutics AG | 5.23B | -0.26% | 1,270,884 | 13.39M |
| 164 | MMSI | Merit Medical Systems, Inc. | 5.19B | -0.57% | 551,091 | 1.58B |
| 165 | DFTX | Definium Therapeutics, Inc. | 5.16B | 6.19% | 2,994,467 | - |
| 166 | IOVA | Iovance Biotherapeutics, Inc. | 4.98B | -0.09% | 12,233,229 | 324.97M |
| 167 | ERAS | Erasca, Inc. | 4.94B | -0.84% | 3,597,312 | - |
| 168 | WAY | Waystar Holding Corp. | 4.94B | 4.21% | 1,928,607 | 1.21B |
| 169 | DNTH | Dianthus Therapeutics, Inc. | 4.91B | -0.81% | 652,710 | 1.90M |
| 170 | HAE | Haemonetics Corporation | 4.81B | 0.47% | 472,150 | 1.35B |
| 171 | MANE | Veradermics, Incorporated | 4.80B | -1.35% | 638,130 | - |
| 172 | DOCS | Doximity, Inc. | 4.67B | -0.57% | 3,035,534 | 655.57M |
| 173 | ADPT | Adaptive Biotechnologies Corporation | 4.55B | -3.13% | 2,638,957 | 308.08M |
| 174 | LFST | LifeStance Health Group, Inc. | 4.52B | - | 3,043,439 | 1.58B |
| 175 | ABCL | AbCellera Biologics Inc. | 4.51B | 9.61% | 7,832,046 | 66.17M |
| 176 | CON | Concentra Group Holdings Parent, Inc. | 4.51B | 1.00% | 594,956 | 2.29B |
| 177 | HTFL | HeartFlow, Inc. | 4.34B | 1.53% | 1,121,107 | 212.07M |
| 178 | EWTX | Edgewise Therapeutics, Inc. | 4.32B | 1.14% | 2,983,865 | - |
| 179 | ITGR | Integer Holdings Corporation | 4.30B | 0.03% | 1,681,806 | 1.84B |
| 180 | LIVN | LivaNova PLC | 4.25B | 0.76% | 570,681 | 1.47B |
| 181 | ICUI | ICU Medical, Inc. | 4.10B | -0.56% | 290,624 | 2.16B |
| 182 | TNGX | Tango Therapeutics, Inc. | 4.10B | -2.49% | 2,413,504 | 53.81M |
| 183 | PBLS | Parabilis Medicines, Inc. | 4.02B | 4.39% | 809,591 | 148.00K |
| 184 | CELC | Celcuity Inc. | 3.90B | 0.15% | 610,352 | - |
| 185 | RLAY | Relay Therapeutics, Inc. | 3.88B | 1.26% | 1,846,400 | 10.35M |
| 186 | VKTX | Viking Therapeutics, Inc. | 3.85B | -7.11% | 8,575,448 | - |
| 187 | TLX | Telix Pharmaceuticals Limited | 3.84B | 1.48% | 851,000 | 890.79M |
| 188 | NVST | Envista Holdings Corporation | 3.81B | -0.92% | 2,571,416 | 2.86B |
| 189 | AMLX | Amylyx Pharmaceuticals, Inc. | 3.75B | 1.22% | 1,020,546 | -665.00K |
| 190 | PLSE | Pulse Biosciences, Inc. | 3.73B | 1.34% | 374,814 | 1.19M |
| 191 | IRTC | iRhythm Holdings, Inc. | 3.71B | 2.01% | 454,729 | 825.34M |
| 192 | IDYA | IDEAYA Biosciences, Inc. | 3.69B | 4.17% | 1,053,735 | 234.13M |
| 193 | VCYT | Veracyte, Inc. | 3.64B | -0.44% | 1,696,528 | 561.90M |
| 194 | LEGN | Legend Biotech Corporation | 3.61B | -2.56% | 1,714,951 | 1.27B |
| 195 | OGN | Organon & Co. | 3.61B | - | 1,989,674 | 6.13B |
| 196 | XENE | Xenon Pharmaceuticals Inc. | 3.56B | -0.60% | 2,515,776 | 7.50M |
| 197 | NHC | National HealthCare Corporation | 3.54B | -0.61% | 92,620 | 1.56B |
| 198 | ACAD | Acadia Pharmaceuticals Inc. | 3.54B | -0.73% | 3,522,828 | 1.14B |
| 199 | ARQT | Arcutis Biotherapeutics, Inc. | 3.44B | 1.52% | 3,065,558 | 463.98M |
| 200 | OPCH | Option Care Health, Inc. | 3.43B | -0.74% | 1,889,356 | 5.69B |
| 201 | ELVN | Enliven Therapeutics, Inc. | 3.37B | 2.82% | 1,284,648 | - |
| 202 | TARS | Tarsus Pharmaceuticals, Inc. | 3.37B | 1.48% | 1,309,604 | 606.33M |
| 203 | DNLI | Denali Therapeutics Inc. | 3.35B | 2.89% | 2,559,529 | 3.60M |
| 204 | CDNA | CareDx, Inc. | 3.34B | 1.44% | 1,081,866 | 458.09M |
| 205 | RCUS | Arcus Biosciences, Inc. | 3.18B | 0.16% | 1,249,287 | 117.00M |
| 206 | RGC | Regencell Bioscience Holdings Limited | 3.07B | 0.49% | 76,162 | - |
| 207 | DYN | Dyne Therapeutics, Inc. | 3.05B | 1.93% | 2,306,034 | - |
| 208 | WRBY | Warby Parker Inc. | 3.05B | -7.68% | 3,250,125 | 911.61M |
| 209 | NEOG | Neogen Corporation | 2.99B | -0.29% | 7,572,577 | 870.40M |
| 210 | ATRC | AtriCure, Inc. | 2.97B | 0.05% | 1,161,794 | 569.62M |
| 211 | ZLAB | Zai Lab Limited | 2.88B | 2.84% | 884,779 | 449.61M |
| 212 | TMDX | TransMedics Group, Inc. | 2.87B | -3.00% | 422,561 | 668.47M |
| 213 | NAMS | NewAmsterdam Pharma Company N.V. | 2.82B | 4.43% | 2,056,742 | 7.12M |
| 214 | PGEN | Precigen, Inc. | 2.80B | 0.77% | 3,491,109 | 85.72M |
| 215 | MBX | MBX Biosciences, Inc. | 2.77B | 7.29% | 439,613 | - |
| 216 | AVAH | Aveanna Healthcare Holdings Inc. | 2.77B | 2.26% | 2,074,696 | 2.60B |
| 217 | QURE | uniQure N.V. | 2.71B | 2.30% | 1,853,458 | 18.67M |
| 218 | BKD | Brookdale Senior Living Inc. | 2.64B | -0.63% | 3,785,880 | 2.93B |
| 219 | ACHC | Acadia Healthcare Company, Inc. | 2.60B | -0.64% | 1,120,913 | 3.37B |
| 220 | SUPN | Supernus Pharmaceuticals, Inc. | 2.59B | 4.55% | 731,229 | 830.44M |
| 221 | GRDN | Guardian Pharmacy Services, Inc. | 2.58B | -1.14% | 621,481 | 1.46B |
| 222 | WGS | GeneDx Holdings Corp. | 2.56B | -2.79% | 437,031 | 454.43M |
| 223 | AXGN | Axogen, Inc. | 2.54B | -0.07% | 885,856 | 251.17M |
| 224 | PRVA | Privia Health Group, Inc. | 2.54B | 0.81% | 1,399,269 | 2.36B |
| 225 | GPCR | Structure Therapeutics Inc. | 2.50B | -2.41% | 1,282,574 | - |
| 226 | IRON | Disc Medicine, Inc. | 2.49B | -0.49% | 480,550 | - |
| 227 | NEO | NeoGenomics, Inc. | 2.48B | -0.21% | 1,299,284 | 766.30M |
| 228 | CLDX | Celldex Therapeutics, Inc. | 2.47B | 1.25% | 1,824,250 | 158.00K |
| 229 | IMNM | Immunome, Inc. | 2.46B | 1.26% | 945,213 | 4.02M |
| 230 | NRIX | Nurix Therapeutics, Inc. | 2.46B | 2.87% | 2,007,854 | 36.77M |
| 231 | BFLY | Butterfly Network, Inc. | 2.44B | -2.56% | 3,873,785 | 112.14M |
| 232 | BEAM | Beam Therapeutics Inc. | 2.42B | -0.16% | 1,274,362 | 156.04M |
| 233 | HCM | HUTCHMED (China) Limited | 2.41B | 1.36% | 29,671 | 549.12M |
| 234 | TRLV | Trulieve Cannabis Corp. | 2.38B | 1.06% | 1,491,497 | 1.14B |
| 235 | VERA | Vera Therapeutics, Inc. | 2.34B | -0.12% | 1,464,643 | - |
| 236 | SLS | SELLAS Life Sciences Group, Inc. | 2.34B | -0.17% | 3,761,795 | - |
| 237 | VRDN | Viridian Therapeutics, Inc. | 2.33B | 0.49% | 1,339,055 | 71.13M |
| 238 | HRMY | Harmony Biosciences Holdings, Inc. | 2.33B | -3.03% | 874,387 | 959.90M |
| 239 | UFPT | UFP Technologies, Inc. | 2.32B | 1.21% | 104,931 | 631.64M |
| 240 | CLOV | Clover Health Investments, Corp. | 2.30B | -3.56% | 3,333,113 | 2.48B |
| 241 | ADMA | ADMA Biologics, Inc. | 2.27B | 7.89% | 3,568,403 | 512.28M |
| 242 | MLYS | Mineralys Therapeutics, Inc. | 2.27B | -0.89% | 1,700,984 | - |
| 243 | ALMR | Alamar Biosciences, Inc. | 2.26B | -0.58% | 224,702 | 100.42M |
| 244 | PHVS | Pharvaris N.V. | 2.24B | -0.34% | 753,332 | - |
| 245 | PBH | Prestige Consumer Healthcare Inc. | 2.22B | 0.69% | 651,764 | 1.10B |
| 246 | SDGR | Schrödinger, Inc. | 2.21B | 2.25% | 2,130,737 | 259.04M |
| 247 | AUPH | Aurinia Pharmaceuticals Inc. | 2.20B | 0.49% | 626,248 | 311.51M |
| 248 | ALVO | Alvotech | 2.20B | 6.96% | 1,436,374 | 494.61M |
| 249 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.16B | -1.40% | 4,354,766 | 940.61M |
| 250 | BHC | Bausch Health Companies Inc. | 2.16B | 1.41% | 1,508,740 | 10.85B |
| 251 | ADRX | ADARx Pharmaceuticals, Inc. | 2.15B | 3.82% | 1,205,216 | 6.13M |
| 252 | PRGO | Perrigo Company plc | 2.10B | -2.08% | 2,889,416 | 4.14B |
| 253 | NKTR | Nektar Therapeutics | 2.06B | 5.85% | 1,376,162 | 54.59M |
| 254 | VCEL | Vericel Corporation | 2.06B | 1.33% | 643,091 | 306.30M |
| 255 | MD | Pediatrix Medical Group, Inc. | 2.06B | -1.44% | 629,320 | 1.95B |
| 256 | TRVI | Trevi Therapeutics, Inc. | 2.05B | -0.07% | 1,613,733 | - |
| 257 | ADUS | Addus HomeCare Corporation | 2.05B | -1.13% | 205,408 | 1.48B |
| 258 | INSP | Inspire Medical Systems, Inc. | 2.02B | -0.71% | 442,263 | 898.74M |
| 259 | PVLA | Palvella Therapeutics, Inc. | 2.01B | 1.21% | 188,616 | - |
| 260 | BHVN | Biohaven Ltd. | 2.00B | 2.16% | 2,046,968 | - |
| 261 | URGN | UroGen Pharma Ltd. | 2.00B | -1.09% | 1,165,647 | 188.73M |
| 262 | AGIO | Agios Pharmaceuticals, Inc. | 2.00B | 2.58% | 1,347,679 | 98.34M |
| 263 | SRPT | Sarepta Therapeutics, Inc. | 1.99B | 0.70% | 2,268,391 | 1.97B |
| 264 | RXRX | Recursion Pharmaceuticals, Inc. | 1.98B | -1.07% | 13,058,804 | 54.86M |
| 265 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.98B | 0.39% | 1,942,350 | 208.78M |
| 266 | NUVB | Nuvation Bio Inc. | 1.97B | -2.44% | 4,592,453 | 169.90M |
| 267 | PGNY | Progyny, Inc. | 1.96B | 0.31% | 1,080,729 | 1.31B |
| 268 | ESTA | Establishment Labs Holdings Inc. | 1.95B | -0.95% | 345,900 | 245.82M |
| 269 | ZYME | Zymeworks Inc. | 1.92B | 2.26% | 1,375,692 | 37.13M |
| 270 | MESO | Mesoblast Limited | 1.92B | -4.10% | 243,048 | 120.25M |
| 271 | LKFT | Lakefront Biotherapeutics NV | 1.92B | 1.57% | 206,618 | 1.13B |
| 272 | BLFS | BioLife Solutions, Inc. | 1.91B | 1.71% | 1,326,517 | 106.69M |
| 273 | GENB | Generate Biomedicines, Inc. | 1.91B | -1.58% | 1,135,539 | 26.48M |
| 274 | FTRE | Fortrea Holdings Inc. | 1.91B | 0.85% | 1,624,703 | 2.68B |
| 275 | SGRY | Surgery Partners, Inc. | 1.91B | 2.01% | 1,103,799 | 3.37B |
| 276 | XNCR | Xencor, Inc. | 1.90B | 7.56% | 1,532,262 | 104.97M |
| 277 | LMAT | LeMaitre Vascular, Inc. | 1.88B | 1.01% | 238,904 | 262.43M |
| 278 | SEPN | Septerna, Inc. | 1.85B | 5.22% | 338,338 | 98.88M |
| 279 | XRAY | DENTSPLY SIRONA Inc. | 1.85B | -1.28% | 5,676,420 | 3.64B |
| 280 | NVCR | NovoCure Limited | 1.84B | -0.06% | 895,992 | 699.19M |
| 281 | CMPS | COMPASS Pathways plc | 1.83B | 1.30% | 1,782,301 | - |
| 282 | ASTH | Astrana Health, Inc. | 1.80B | -3.41% | 363,554 | 3.84B |
| 283 | ZBIO | Zenas BioPharma, Inc. | 1.80B | 2.23% | 615,348 | 1.00M |
| 284 | XERS | Xeris Biopharma Holdings, Inc. | 1.79B | 8.02% | 4,463,349 | 335.41M |
| 285 | SNDA | Sonida Senior Living, Inc. | 1.78B | -0.27% | 271,474 | 481.07M |
| 286 | NVAX | Novavax, Inc. | 1.78B | 1.60% | 4,461,696 | 413.80M |
| 287 | VIR | Vir Biotechnology, Inc. | 1.78B | -1.41% | 1,369,980 | 303.23M |
| 288 | PSNL | Personalis, Inc. | 1.74B | -0.85% | 1,669,453 | 69.67M |
| 289 | FRNM | Freenome, Inc. | 1.74B | 1.25% | 255,886 | 35.41M |
| 290 | ETON | Eton Pharmaceuticals, Inc. | 1.69B | 2.60% | 390,726 | 105.60M |
| 291 | OCUL | Ocular Therapeutix, Inc. | 1.68B | -20.67% | 15,442,390 | 52.06M |
| 292 | KMTS | Kestra Medical Technologies, Ltd. | 1.68B | 3.65% | 292,897 | 106.73M |
| 293 | STOK | Stoke Therapeutics, Inc. | 1.65B | 2.82% | 1,660,270 | 27.59M |
| 294 | ALHC | Alignment Healthcare, Inc. | 1.64B | -3.41% | 8,666,426 | 4.58B |
| 295 | ABSI | Absci Corporation | 1.63B | -2.57% | 3,252,941 | 1.56M |
| 296 | TSHA | Taysha Gene Therapies, Inc. | 1.63B | 6.85% | 6,262,455 | 5.49M |
| 297 | NBTX | Nanobiotix S.A. | 1.61B | -2.13% | 49,384 | 13.15M |
| 298 | GHRS | GH Research PLC | 1.61B | -1.76% | 609,725 | - |
| 299 | RAPP | Rapport Therapeutics, Inc. | 1.60B | -1.39% | 552,307 | 20.00M |
| 300 | ANIP | ANI Pharmaceuticals, Inc. | 1.60B | 1.12% | 421,727 | 978.38M |
| 301 | NTLA | Intellia Therapeutics, Inc. | 1.60B | -2.81% | 3,299,995 | 59.51M |
| 302 | SNDX | Syndax Pharmaceuticals, Inc. | 1.59B | -1.87% | 1,554,158 | 252.25M |
| 303 | IMCR | Immunocore Holdings plc | 1.58B | -0.26% | 266,623 | 430.78M |
| 304 | ATEC | Alphatec Holdings, Inc. | 1.55B | -0.69% | 1,706,604 | 815.05M |
| 305 | COAG | Hemab Therapeutics Holdings, Inc. | 1.55B | -4.66% | 348,532 | - |
| 306 | OMCL | Omnicell, Inc. | 1.54B | 0.62% | 563,604 | 1.25B |
| 307 | INVA | Innoviva, Inc. | 1.53B | 2.36% | 854,634 | 440.00M |
| 308 | ANAB | AnaptysBio, Inc. | 1.52B | -0.39% | 412,660 | 106.09M |
| 309 | AZTA | Azenta, Inc. | 1.50B | 0.68% | 736,977 | 613.81M |
| 310 | INBX | Inhibrx Biosciences, Inc. | 1.50B | 2.11% | 188,883 | 1.30M |
| 311 | MAZE | Maze Therapeutics, Inc. | 1.49B | 3.07% | 1,177,351 | 20.00M |
| 312 | ARDT | Ardent Health, Inc. | 1.48B | -0.66% | 408,687 | 6.41B |
| 313 | TYRA | Tyra Biosciences, Inc. | 1.47B | -1.42% | 824,582 | - |
| 314 | NUTX | Nutex Health Inc. | 1.46B | -3.35% | 163,475 | 846.72M |
| 315 | PAHC | Phibro Animal Health Corporation | 1.45B | 3.63% | 485,902 | 1.52B |
| 316 | AVBP | ArriVent BioPharma, Inc. | 1.44B | 2.99% | 1,016,621 | - |
| 317 | KLRA | Kailera Therapeutics, Inc. | 1.44B | -0.89% | 1,433,497 | - |
| 318 | PNTG | The Pennant Group, Inc. | 1.43B | 0.32% | 461,332 | 1.10B |
| 319 | HCSG | Healthcare Services Group, Inc. | 1.43B | -1.28% | 573,122 | 1.86B |
| 320 | RARE | Ultragenyx Pharmaceutical Inc. | 1.42B | -0.62% | 4,939,905 | 717.00M |
| 321 | OMER | Omeros Corporation | 1.41B | -3.24% | 1,026,396 | 38.42M |
| 322 | KRSA | Korsana Biosciences, Inc. | 1.40B | -0.55% | 51,565 | - |
| 323 | CERT | Certara, Inc. | 1.39B | 0.22% | 2,943,636 | 421.75M |
| 324 | CNMD | CONMED Corporation | 1.39B | 2.42% | 374,847 | 1.37B |
| 325 | DRTS | Alpha Tau Medical Ltd. | 1.39B | 3.44% | 397,839 | - |
| 326 | AAPG | Ascentage Pharma Group International | 1.38B | 0.20% | 4,961 | 94.61M |
| 327 | KARD | Kardigan, Inc. | 1.38B | -0.07% | 364,855 | - |
| 328 | BRVE | Braveheart Bio, Inc. | 1.38B | 2.18% | 389,297 | - |
| 329 | ORIC | ORIC Pharmaceuticals, Inc. | 1.38B | 0.84% | 1,515,563 | - |
| 330 | AGL | agilon health, inc. | 1.34B | -1.49% | 211,789 | 5.92B |
| 331 | AMN | AMN Healthcare Services, Inc. | 1.33B | -0.87% | 341,483 | 3.43B |
| 332 | TRAX | First Tracks Biotherapeutics, Inc. | 1.31B | 6.46% | 674,498 | - |
| 333 | SVRA | Savara Inc. | 1.29B | 1.40% | 4,371,598 | - |
| 334 | USPH | U.S. Physical Therapy, Inc. | 1.28B | 1.47% | 196,532 | 804.27M |
| 335 | DMRA | Damora Therapeutics, Inc. | 1.28B | 0.44% | 514,956 | - |
| 336 | IART | Integra LifeSciences Holdings Corporation | 1.27B | 0.93% | 479,048 | 1.65B |
| 337 | CRON | Cronos Group Inc. | 1.26B | 2.10% | 1,134,280 | 179.09M |
| 338 | AVLN | Avalyn Pharma Inc. | 1.26B | 0.85% | 205,866 | - |
| 339 | BCAX | Bicara Therapeutics Inc. | 1.24B | -2.13% | 775,257 | - |
| 340 | LBRX | LB Pharmaceuticals Inc | 1.22B | 1.50% | 534,588 | - |
| 341 | OPK | OPKO Health, Inc. | 1.22B | -0.61% | 1,608,932 | 587.90M |
| 342 | INNV | InnovAge Holding Corp. | 1.21B | -1.22% | 725,519 | 989.71M |
| 343 | OMDA | Omada Health, Inc. | 1.19B | -1.37% | 1,762,190 | 309.76M |
| 344 | HROW | Harrow, Inc. | 1.18B | -4.45% | 852,454 | 275.59M |
| 345 | REPL | Replimune Group, Inc. | 1.18B | 1.62% | 1,966,732 | - |
| 346 | BVS | Bioventus Inc. | 1.18B | 1.52% | 588,671 | 581.85M |
| 347 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.17B | 4.82% | 751,802 | 730.02M |
| 348 | IMTX | Immatics N.V. | 1.16B | 1.55% | 1,467,545 | 47.65M |
| 349 | LTGO | Latigo Biotherapeutics, Inc. | 1.16B | 1.92% | 261,933 | - |
| 350 | TNDM | Tandem Diabetes Care, Inc. | 1.14B | 4.45% | 2,852,543 | 1.04B |
| 351 | GDRX | GoodRx Holdings, Inc. | 1.13B | -1.19% | 694,199 | 785.23M |
| 352 | AORT | Artivion, Inc. | 1.12B | 1.41% | 446,062 | 471.47M |
| 353 | IRMD | IRADIMED CORPORATION | 1.11B | 1.05% | 150,692 | 86.34M |
| 354 | SLBT | SL Science Holding Limited | 1.10B | 22.93% | 284,688 | 3.27M |
| 355 | CSTL | Castle Biosciences, Inc. | 1.10B | 0.34% | 228,426 | 357.28M |
| 356 | VOR | Vor Biopharma Inc. | 1.08B | -1.13% | 930,101 | - |
| 357 | BBNX | Beta Bionics, Inc. | 1.08B | -4.60% | 1,760,467 | 119.01M |
| 358 | MNKD | MannKind Corporation | 1.08B | 0.30% | 2,077,517 | 393.63M |
| 359 | AKTS | Aktis Oncology, Inc. | 1.08B | -0.41% | 223,200 | 10.06M |
| 360 | TDOC | Teladoc Health, Inc. | 1.07B | -3.28% | 4,150,922 | 2.49B |
| 361 | MGTX | MeiraGTx Holdings plc | 1.07B | 1.83% | 930,005 | 397.50M |
| 362 | SPTX | Seaport Therapeutics, Inc. | 1.05B | -8.74% | 284,478 | - |
| 363 | ENOV | Enovis Corporation | 1.05B | -1.63% | 1,466,375 | 2.30B |
| 364 | STAA | STAAR Surgical Company | 1.05B | 1.76% | 540,758 | 339.59M |
| 365 | ANRO | Alto Neuroscience, Inc. | 1.05B | 0.64% | 587,005 | - |
| 366 | ODTX | Odyssey Therapeutics, Inc. | 1.03B | 4.68% | 213,055 | 99.00K |
| 367 | JANX | Janux Therapeutics, Inc. | 1.01B | 1.72% | 473,051 | 24.00M |
| 368 | PCRX | Pacira BioSciences, Inc. | 1.01B | 1.07% | 483,057 | 746.16M |
| 369 | GLUE | Monte Rosa Therapeutics, Inc. | 999.02M | -0.51% | 772,655 | 28.73M |
| 370 | CRVS | Corvus Pharmaceuticals, Inc. | 998.52M | 2.15% | 1,210,421 | - |
| 371 | ANL | Adlai Nortye Group Ltd. | 991.73M | -0.84% | 63,506 | 18.06M |
| 372 | PRCT | PROCEPT BioRobotics Corporation | 987.97M | 0.29% | 1,749,461 | 337.34M |
| 373 | MLTX | MoonLake Immunotherapeutics | 983.83M | -3.99% | 1,656,878 | - |
| 374 | LMRI | Lumexa Imaging Holdings, Inc. | 974.68M | -0.64% | 165,287 | 1.04B |
| 375 | CGEM | Cullinan Therapeutics, Inc. | 962.10M | 0.95% | 1,109,221 | - |
| 376 | ABUS | Arbutus Biopharma Corporation | 961.54M | 0.21% | 11,669,573 | 181.72M |
| 377 | KURA | Kura Oncology, Inc. | 943.87M | -1.39% | 1,646,316 | 77.23M |
| 378 | CBLL | CeriBell, Inc. | 940.65M | 3.46% | 217,930 | 101.96M |
| 379 | ALMS | Alumis Inc. | 926.76M | 0.85% | 2,245,383 | 7.40M |
| 380 | RIGL | Rigel Pharmaceuticals, Inc. | 922.04M | 2.45% | 180,879 | 276.79M |
| 381 | HELP | Cybin Inc. | 919.83M | -0.16% | 986,597 | - |
| 382 | JBIO | Jade Biosciences, Inc. | 912.62M | -0.49% | 598,628 | - |
| 383 | APMD | Apnimed, Inc. | 902.14M | 2.75% | 283,858 | 115.12M |
| 384 | HSTM | HealthStream, Inc. | 891.56M | 0.14% | 144,586 | 321.12M |
| 385 | SANA | Sana Biotechnology, Inc. | 877.13M | -0.51% | 2,265,906 | - |
| 386 | SGP | SpyGlass Pharma, Inc. | 868.98M | -4.03% | 119,999 | - |
| 387 | CADL | Candel Therapeutics, Inc. | 856.24M | 1.54% | 771,017 | - |
| 388 | ARDX | Ardelyx, Inc. | 849.73M | -0.29% | 3,318,164 | 450.89M |
| 389 | LXRX | Lexicon Pharmaceuticals, Inc. | 845.42M | 5.85% | 10,893,992 | 41.47M |
| 390 | SIBN | SI-BONE, Inc. | 840.80M | 0.91% | 461,560 | 213.60M |
| 391 | OBX | Obsidian Therapeutics, Inc. | 825.90M | 3.97% | 912,962 | - |
| 392 | IMMX | Immix Biopharma, Inc. | 820.56M | 4.56% | 995,932 | - |
| 393 | INMD | InMode Ltd. | 816.51M | -0.39% | 201,736 | 374.63M |
| 394 | AVTX | Avalo Therapeutics, Inc. | 808.74M | -2.52% | 749,653 | 59.00K |
| 395 | ATTO | Attovia Therapeutics, Inc. | 805.74M | -0.73% | 403,112 | 1.80M |
| 396 | FDMT | 4D Molecular Therapeutics, Inc. | 804.36M | 0.62% | 1,557,430 | 92.01M |
| 397 | GERN | Geron Corporation | 803.09M | -0.79% | 9,974,090 | 204.56M |
| 398 | ACRS | Aclaris Therapeutics, Inc. | 799.29M | 5.44% | 2,429,168 | 8.22M |
| 399 | ACHV | Achieve Life Sciences, Inc. | 797.49M | 2.79% | 1,301,102 | - |
| 400 | GYRE | Gyre Therapeutics, Inc. | 794.19M | 1.90% | 137,050 | 109.82M |
| 401 | IVA | Inventiva S.A. | 793.87M | 4.75% | 3,484,274 | 2.81M |
| 402 | SLDB | Solid Biosciences Inc. | 780.60M | -0.14% | 1,413,513 | - |
| 403 | GMRS | GMR Solutions Inc. | 778.77M | -9.40% | 1,086,888 | 5.88B |
| 404 | VREX | Varex Imaging Corporation | 778.05M | 0.05% | 441,634 | 865.00M |
| 405 | DSGN | Design Therapeutics, Inc. | 773.51M | 1.98% | 433,134 | - |
| 406 | ANNX | Annexon, Inc. | 760.21M | 10.16% | 5,072,611 | - |
| 407 | AVR | Anteris Technologies Global Corp. | 754.33M | 0.65% | 707,188 | 2.24M |
| 408 | AHCO | AdaptHealth Corp. | 753.76M | 0.18% | 1,589,553 | 3.36B |
| 409 | OLMA | Olema Pharmaceuticals, Inc. | 753.35M | -1.60% | 979,229 | - |
| 410 | CTKB | Cytek Biosciences, Inc. | 746.10M | 1.59% | 1,085,779 | 206.71M |
| 411 | QDEL | QuidelOrtho Corporation | 742.67M | -1.01% | 760,160 | 2.67B |
| 412 | PHAR | Pharming Group N.V. | 740.37M | 0.57% | 15,478 | 366.48M |
| 413 | COLL | Collegium Pharmaceutical, Inc. | 736.73M | 0.44% | 687,384 | 808.21M |
| 414 | WVE | Wave Life Sciences, Inc. | 723.17M | -2.91% | 3,546,374 | 65.37M |
| 415 | SOPH | SOPHiA GENETICS SA | 722.74M | 1.80% | 547,679 | 86.17M |
| 416 | FTH | Faeth Therapeutics, Inc. | 717.59M | -0.82% | 195,647 | - |
| 417 | ETRA | Electra Therapeutics, Inc. | 710.52M | -1.99% | 537,145 | - |
| 418 | DNA | Ginkgo Bioworks Holdings, Inc. | 704.38M | -1.88% | 2,122,119 | 132.42M |
| 419 | VSTM | Verastem, Inc. | 703.68M | 0.39% | 1,260,637 | 87.53M |
| 420 | DBVT | DBV Technologies S.A. | 697.14M | 0.69% | 712,947 | 5.04M |
| 421 | OABI | OmniAb, Inc. | 689.15M | 2.82% | 674,966 | 38.46M |
| 422 | MDXG | MiMedx Group, Inc. | 682.16M | 0.21% | 881,299 | 355.17M |
| 423 | IRWD | Ironwood Pharmaceuticals, Inc. | 680.79M | -0.24% | 1,962,719 | 389.32M |
| 424 | BLSM | BlossomHill Therapeutics, Inc. | 678.29M | 8.05% | 146,425 | - |
| 425 | NVCT | Nuvectis Pharma, Inc. | 678.02M | 2.92% | 137,909 | - |
| 426 | STLN | Starling Oncology, Inc. | 676.72M | -0.30% | 919,193 | 587.24M |
| 427 | SLN | Silence Therapeutics plc | 674.34M | 0.18% | 710,712 | 615.00K |
| 428 | CLYM | Climb Bio, Inc. | 674.30M | 0.69% | 811,300 | - |
| 429 | ZVRA | Zevra Therapeutics, Inc. | 671.04M | 2.36% | 751,309 | 136.07M |
| 430 | GLAS | Glass House Brands Inc. | 645.56M | 0.74% | 1,585,130 | 176.98M |
| 431 | STTK | Shattuck Labs, Inc. | 645.34M | 5.93% | 976,892 | 1.00M |
| 432 | ANGO | AngioDynamics, Inc. | 642.31M | 0.32% | 533,568 | 320.17M |
| 433 | AURA | Aura Biosciences, Inc. | 637.78M | 2.50% | 483,658 | - |
| 434 | PHR | Phreesia, Inc. | 626.92M | -0.49% | 645,908 | 507.79M |
| 435 | AHG | Akso Health Group | 626.25M | -2.53% | 48,098 | 13.83M |
| 436 | CBIO | Crescent Biopharma, Inc. | 621.90M | 3.86% | 294,758 | 11.88M |
| 437 | SGMT | Sagimet Biosciences Inc. | 617.86M | 7.58% | 1,345,966 | - |
| 438 | FLGT | Fulgent Genetics, Inc. | 615.24M | 0.72% | 249,059 | 323.93M |
| 439 | CRMD | CorMedix Inc. | 614.98M | 0.51% | 485,279 | 462.25M |
| 440 | VALN | Valneva SE | 597.30M | 5.37% | 21,570 | 163.30M |
| 441 | AQST | Aquestive Therapeutics, Inc. | 596.18M | 1.50% | 1,276,835 | 54.09M |
| 442 | WEAV | Weave Communications, Inc. | 589.59M | 0.27% | 851,628 | 257.79M |
| 443 | KIDS | OrthoPediatrics Corp. | 589.56M | 0.13% | 157,937 | 252.72M |
| 444 | CTMX | CytomX Therapeutics, Inc. | 586.15M | -0.37% | 2,694,060 | 18.30M |
| 445 | PHAT | Phathom Pharmaceuticals, Inc. | 583.81M | 0.68% | 1,690,908 | 239.66M |
| 446 | MPLT | MapLight Therapeutics, Inc. | 580.77M | -0.10% | 251,569 | - |
| 447 | SSII | SS Innovations International, Inc. | 579.11M | -2.03% | 29,492 | 52.40M |
| 448 | EVO | Evotec SE | 578.01M | 1.92% | 187,825 | 819.47M |
| 449 | ALT | Altimmune, Inc. | 575.77M | -3.27% | 3,359,772 | 31.00K |
| 450 | NGNE | Neurogene Inc. | 569.92M | 0.60% | 176,387 | 925.00K |
| 451 | ALLO | Allogene Therapeutics, Inc. | 563.15M | -1.21% | 5,026,155 | 4.64M |
| 452 | MNPR | Monopar Therapeutics Inc. | 561.94M | -1.78% | 268,175 | - |
| 453 | OCS | Oculis Holding AG | 559.29M | -2.27% | 266,992 | 1.45M |
| 454 | TLRY | Tilray Brands, Inc. | 550.71M | -2.66% | 3,794,878 | 915.45M |
| 455 | DCTH | Delcath Systems, Inc. | 548.59M | 1.35% | 304,239 | 95.42M |
| 456 | EPRX | Eupraxia Pharmaceuticals Inc. | 541.98M | 2.50% | 369,124 | - |
| 457 | PACB | Pacific Biosciences of California, Inc. | 531.52M | 5.56% | 21,281,906 | 159.27M |
| 458 | BWAY | BrainsWay Ltd. | 525.78M | -0.45% | 179,074 | 60.70M |
| 459 | EOLS | Evolus, Inc. | 525.76M | -0.13% | 478,232 | 316.49M |
| 460 | SENS | Senseonics Holdings, Inc. | 520.28M | -1.60% | 566,650 | 48.55M |
| 461 | TCMD | Tactile Systems Technology, Inc. | 516.93M | 0.40% | 151,428 | 350.31M |
| 462 | PRME | Prime Medicine, Inc. | 511.47M | -0.86% | 3,682,473 | 4.07M |
| 463 | DRUG | Bright Minds Biosciences Inc. | 511.00M | -0.27% | 91,880 | - |
| 464 | SGHT | Sight Sciences, Inc. | 510.67M | 3.81% | 468,531 | 83.38M |
| 465 | PBYI | Puma Biotechnology, Inc. | 506.91M | 0.51% | 245,941 | 231.24M |
| 466 | CAPR | Capricor Therapeutics, Inc. | 506.39M | 4.19% | 2,097,252 | 11.13M |
| 467 | MCTA | Charming Medical Limited | 504.26M | -0.85% | - | 4.81M |
| 468 | YDES | YD Bio Limited | 503.61M | 24.08% | 508,320 | 1.24M |
| 469 | AGMB | AgomAb Therapeutics NV | 502.82M | -2.85% | 147,156 | - |
| 470 | KMDA | Kamada Ltd. | 496.72M | -1.15% | 147,954 | 191.85M |
| 471 | AUTL | Autolus Therapeutics plc | 495.06M | 0.27% | 1,399,645 | 117.39M |
| 472 | TKNO | Alpha Teknova, Inc. | 493.93M | -1.39% | 222,483 | 43.70M |
| 473 | CERS | Cerus Corporation | 493.74M | -6.49% | 1,512,783 | 221.55M |
| 474 | RGNX | REGENXBIO Inc. | 493.12M | 0.95% | 1,325,849 | 174.48M |
| 475 | ARVN | Arvinas, Inc. | 491.05M | -1.05% | 512,105 | 316.70M |
| 476 | PROK | ProKidney Corp. | 486.74M | 0.63% | 1,814,559 | 818.00K |
| 477 | NPCE | NeuroPace, Inc. | 485.69M | 0.64% | 134,551 | 106.99M |
| 478 | MASS | 908 Devices Inc. | 481.95M | 1.92% | 287,349 | 60.84M |
| 479 | ASMB | Assembly Biosciences, Inc. | 480.71M | -0.25% | 117,454 | 74.85M |
| 480 | OVID | Ovid Therapeutics Inc. | 480.43M | 2.50% | 1,192,530 | 1.58M |
| 481 | CTNM | Contineum Therapeutics, Inc. | 478.92M | 1.35% | 534,128 | - |
| 482 | CLPT | ClearPoint Neuro, Inc. | 467.02M | 3.24% | 478,690 | 42.28M |
| 483 | ENTX | Entera Bio Ltd. | 465.75M | -2.00% | 340,911 | 42.00K |
| 484 | SRTA | Strata Critical Medical, Inc. | 462.68M | -1.88% | 654,359 | 255.98M |
| 485 | TECX | Tectonic Therapeutic, Inc. | 459.61M | -0.68% | 234,838 | - |
| 486 | DMAC | DiaMedica Therapeutics Inc. | 448.66M | 4.79% | 362,953 | - |
| 487 | PRTA | Prothena Corporation plc | 447.66M | 5.19% | 488,859 | 54.53M |
| 488 | NRC | NRC Health | 443.72M | 2.50% | 83,319 | 140.00M |
| 489 | RZLT | Rezolute, Inc. | 438.47M | 7.18% | 1,587,556 | - |
| 490 | INDP | Indaptus Therapeutics, Inc. | 438.37M | -14.55% | 584,287 | - |
| 491 | EIKN | Eikon Therapeutics, Inc. | 428.45M | -0.13% | 435,024 | - |
| 492 | AGEN | Agenus Inc. | 424.54M | 10.42% | 2,766,015 | 132.69M |
| 493 | KYTX | Kyverna Therapeutics, Inc. | 421.77M | 0.15% | 997,818 | - |
| 494 | IRD | Opus Genetics, Inc. | 420.14M | 6.09% | 1,162,237 | 9.86M |
| 495 | AVIR | Atea Pharmaceuticals, Inc. | 417.06M | 0.58% | 238,374 | - |
| 496 | EVH | Evolent Health, Inc. | 412.67M | 1.11% | 3,397,882 | 2.10B |
| 497 | SCTX | Scribe Therapeutics Inc. | 412.14M | 2.30% | 307,497 | 33.30M |
| 498 | ARCT | Arcturus Therapeutics Holdings Inc. | 411.00M | 4.40% | 825,022 | 29.37M |
| 499 | SPRY | ARS Pharmaceuticals, Inc. | 410.72M | 1.23% | 949,893 | 116.93M |
| 500 | MYGN | Myriad Genetics, Inc. | 405.55M | 1.68% | 1,181,318 | 806.60M |